NCT00486122View on ClinicalTrials.gov

Evaluation of Continuous Symptom Treatment of ADHD

PHASE4CompletedINTERVENTIONAL

Enrollment

282

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

June 30, 2004

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Atomoxetine Hydrochloride

DRUG

Placebo

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Columbus

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00486122 - Evaluation of Continuous Symptom Treatment of ADHD | Biotech Hunter | Biotech Hunter